UCSF-Led Study Explains How Early Childhood Vaccination Reduces Leukemia Risk
A team led by UCSF researchers has discovered how a commonly administered vaccine protects against acute lymphoblastic leukemia, the most common type of childhood cancer.
![](/sites/default/files/styles/news_card__image/public/field/image/news/leukemia.png)
University of California San Francisco
Give to UCSFA team led by UCSF researchers has discovered how a commonly administered vaccine protects against acute lymphoblastic leukemia, the most common type of childhood cancer.
An online smoking cessation program that offered personalized guidance and support free of charge to smokers worldwide prompted thousands to quit, and should be used as a blueprint for other global health initiatives, according to Ricardo F. Muñoz, PhD, professor emeritus of psychiatry at UCSF
A team led by UCSF scientists has discovered a possible reason why angiogenesis inhibitors often work in the short term but usually become ineffective within months, one that could lead to a way to prevent cancer relapse.
UCSF scientists have identified a biological escape hatch that explains the resistance to targeted drug treatment in some lung cancer patients.
A research team at UCSF has won a five-year award of $14.1 million from the Patient-Centered Outcomes Research Institute to investigate whether a personalized approach to breast cancer screening is as safe and effective as annual mammograms.
A new study of acute lymphoblastic leukemia led by UCSF researchers puts an intriguing new twist on anti-cancer strategies.
UCSF Chancellor and Professor Emeritus J. Michael Bishop, MD, Professor Emeritus Harold Varmus, MD, and Chancellor and Professor Emeritus Susan Desmond-Hellmann, MD, MPH, will be highlighted for their pioneering work on cancer in the Ken Burns-produced PBS documentary series “Cancer: The Emperor of All Maladies,” which airs March 30-April 1, 2015.
A new study of acute lymphoblastic leukemia has revealed that the disease has two distinct subtypes, and provides preliminary evidence that about 13 percent of cases may be successfully treated with targeted drugs.
Though the headlines have subsided, UCSF volunteers and experts are still hard at work fighting Ebola in West Africa and helping build better infrastructure that could stop another outbreak.
New research finds a special protein may control the survival of deep, near-dormant cancer cells that allow tumors to regrow even after other cells have been eradicated.
A protein called YAP, which drives the growth of organs during development and regulates their size in adulthood, plays a key role in the emergence of resistance to targeted cancer therapies, according to a new study.
With advances in technology and better understanding of people, the health sciences are constantly pushing toward more effective treatments and cures. The question is, where will we see the next breakthroughs in 2015?
An American doctor who contracted Ebola while caring for patients in Sierra Leone spoke at UCSF about his experience after a touch-and-go, 40-day battle with the virus.
The idea of art as medicine dates back to antiquity, but recently the concept is drawing increasing interest from the medical and science communities.